BeiGene Revenue

In the year 2024, BeiGene had annual revenue of $3.81B with 54.96% growth. BeiGene had revenue of $1.19B in the quarter ending December 31, 2024, with 84.84% growth.

Revenue

3.81B

Revenue Growth

+54.96%

P/S Ratio

n/a

Revenue / Employee

346.39K

Employees

11,000

Market Cap

28.75B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.81B	1.35B	54.96%
Dec 31, 2023	2.46B	1.04B	73.65%
Dec 31, 2022	1.42B	239.64M	20.37%
Dec 31, 2021	1.18B	867.41M	280.83%
Dec 31, 2020	308.87M	-119.34M	-27.87%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
SS Innovations International	16.04M
Veradigm	588.02M
Elite Pharmaceuticals	70.00M
Glass House Brands	200.90M
Northwest Biotherapeutics	1.60M
Silence Therapeutics	43.26M
American Oncology Network	1.76B

Revenue Rankings